PixCell Medical

PixCell Medical manufactures HemoScreen, a portable point-of-care (POC) complete blood count (CBC) analyzer designed to perform complex hematological testing in non-laboratory settings. The device delivers results in approximately 5 minutes and includes a 5-part differential count with clinical accuracy comparable to centralized laboratory instruments. The technology employs microfluidics, Lab-On-A-Cartridge design, and viscoelastic focusing—a proprietary physical phenomenon that aligns blood cells into a monolayer for optical analysis. HemoScreen accepts both venous and capillary (finger-stick) samples, enabling deployment in emergency departments, urgent care clinics, oncology practices, mental health facilities, primary care centers, and homecare settings. The company markets to healthcare practitioners and institutions seeking rapid turnaround for critical hematological decision-making. Testimonials from NHS trusts, university medical centers, and international healthcare systems indicate clinical adoption in the UK, Sweden, Denmark, and US. The device has received FDA clearance and is recognized by clinical organizations including AACC for disruptive technology. Manufacturing and service capabilities support both institutional and point-of-care deployment models.